CEND-1 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEND-1 Injection, covering 2024-09-04 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]